WaVe Life Sciences Garners $18,000,000 Series A Financing Round

  • Feed Type
  • Date
    2/3/2015
  • Company Name
    WaVe Life Sciences
  • Mailing Address
    419 Western Avenue Boston, MA 02135 USA
  • Company Description
    WaVe Life Sciences is leading a revolution in nucleic acid therapeutics and was founded on the core principle that medicines should possess precisely controlled molecular structures. We and our strategic partners are advancing a portfolio of stereopure drug candidates that target underlying biology across a wide range of human diseases.
  • Website
    http://www.wavelifesciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    WaVe is using the cash to scale up, and get ready to bring its first drug to clinical trials. It’s got 19 employees as of now.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy